[ Price : $8.95]
Two Hyman, Phelps & McNamara attorneys describe requirements in the new Food and Drug Omnibus Reform Act to improve clinical trial...[ Price : $8.95]
FDA principal deputy commissioner Janet Woodcock says the agency will work with Congress to develop a new cross-agency regulatory ...[ Price : $8.95]
Federal Register notice: FDA announces a 3/9 Oncologic Drugs Advisory Committee meeting to discuss a supplemental BLA for Genentec...[ Price : $8.95]
Federal Register notice: FDA issues a three-year debarment order against Poornanand Palaparty for receiving and distributing presc...[ Price : $8.95]
FDA commissioner Robert Califf and CBER director Peter Marks explain why biological therapies should be tested in randomized contr...[ Price : $8.95]
Two professors call for updates to the FDA system for regulating drug promotion to account for new businesses that are promoting d...[ Price : $8.95]
The CDRH 2022 annual report says the Center responded to many unique and important issues.[ Price : $8.95]
FDA says AstraZenecas Evusheld is no longer authorized for emergency use to fight Covid-19 infections.